Memorial Sloan-Kettering is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan-Kettering has participated in 11 clinical trials.
Therapeutic areas: Acute Lymphoblastic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma, Carcinoma, Non-Small-Cell Lung.
Sponsors: Gilead Sciences, Kite, A Gilead Company, Puma Biotechnology, Inc..
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan-Kettering has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan-Kettering has 11 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma, Carcinoma, Non-Small-Cell Lung.
Yes — Memorial Sloan-Kettering holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.